[go: up one dir, main page]

MX9204138A - Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen - Google Patents

Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen

Info

Publication number
MX9204138A
MX9204138A MX9204138A MX9204138A MX9204138A MX 9204138 A MX9204138 A MX 9204138A MX 9204138 A MX9204138 A MX 9204138A MX 9204138 A MX9204138 A MX 9204138A MX 9204138 A MX9204138 A MX 9204138A
Authority
MX
Mexico
Prior art keywords
formula
compounds
ditiane
procedure
obtaining
Prior art date
Application number
MX9204138A
Other languages
English (en)
Inventor
James F Eliason
Henri Ramuz Franz
Alois Kaufmann-Schmid
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9204138A publication Critical patent/MX9204138A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Compuestos de l a fórmula: (FORMULA) en donde R significa un radical de la fórmula (FORMULA) y R1, R2, R3, R4, R5, R6, R7, X, Y y Z tienen el significado expuesto en la reivindicación 1, con la excepción de rac-N-(3,4-dimetoxifenetil)-2-(3,4-dimetoxifenil)- beta, n-dimetil-m-ditian-2-propilamina, así como sus sales de adición de ácido tienen relevantes propiedades contra células tumorales malignas multi-resistentes y contra resistencia a cloroquina, y son por tanto apropiados para reducir y/o eliminar resistencia múltiple a citostáticos en el tratamiento de tumores o para reducir y/o eliminar resistencia a cloroquina en el tratamiento de malaria.
MX9204138A 1991-07-18 1992-07-15 Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen MX9204138A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH214491 1991-07-18

Publications (1)

Publication Number Publication Date
MX9204138A true MX9204138A (es) 1993-07-01

Family

ID=4226902

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204138A MX9204138A (es) 1991-07-18 1992-07-15 Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen

Country Status (19)

Country Link
US (2) US5302727A (es)
EP (1) EP0523493A1 (es)
JP (1) JPH05208972A (es)
KR (1) KR930002341A (es)
CN (1) CN1031754C (es)
AU (1) AU657142B2 (es)
BR (1) BR9202719A (es)
CA (1) CA2074062A1 (es)
CZ (1) CZ281619B6 (es)
FI (1) FI923292A (es)
HU (1) HUT62285A (es)
IE (1) IE922338A1 (es)
IL (1) IL102477A (es)
MX (1) MX9204138A (es)
NO (1) NO922846L (es)
NZ (1) NZ243545A (es)
TW (1) TW223071B (es)
UY (1) UY23447A1 (es)
ZA (1) ZA925185B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2198752A1 (en) 1994-08-31 1996-03-07 Jason Scott Sawyer Methods for identifying and treating resistant tumors
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
AU2012362105B2 (en) * 2011-12-30 2017-09-07 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
CN105085471B (zh) * 2014-05-16 2019-06-11 兰州大学 一种2-取代-1,3-二噻烷衍生物的制备方法
CN104710404B (zh) * 2015-03-31 2016-03-23 西安科技大学 一种取代-1,3-二噻烷类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003914A (en) * 1973-12-21 1977-01-18 Hoffmann-La Roche Inc. Sulphur containing derivatives
US4127588A (en) * 1976-10-01 1978-11-28 Hoffmann-La Roche Inc. Sulphur containing derivatives

Also Published As

Publication number Publication date
JPH05208972A (ja) 1993-08-20
BR9202719A (pt) 1993-03-23
TW223071B (es) 1994-05-01
FI923292A (fi) 1993-01-19
IL102477A (en) 1996-09-12
CN1031754C (zh) 1996-05-08
HU9202320D0 (en) 1992-10-28
NZ243545A (en) 1994-11-25
HUT62285A (en) 1993-04-28
CZ281619B6 (cs) 1996-11-13
US5405866A (en) 1995-04-11
AU2034992A (en) 1993-01-21
US5302727A (en) 1994-04-12
FI923292A0 (fi) 1992-07-17
CZ218992A3 (en) 1993-02-17
IL102477A0 (en) 1993-01-14
AU657142B2 (en) 1995-03-02
NO922846D0 (no) 1992-07-17
UY23447A1 (es) 1993-01-07
CN1068569A (zh) 1993-02-03
KR930002341A (ko) 1993-02-23
EP0523493A1 (de) 1993-01-20
CA2074062A1 (en) 1993-01-19
NO922846L (no) 1993-01-19
ZA925185B (en) 1993-04-29
IE922338A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
ES8307762A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina.
FR2381803A1 (fr) Compositions a mouler a base de polycarbonate ayant une ininflammabilite amelioree
MX173654B (es) Procedimiento para la preparacion de titanocenos y producto obtenido
ES2040208T3 (es) Pirazolinas insecticidas.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
FR2406641A1 (fr) 2,6-diaminonebularines et leur application therapeutique
AR008387A1 (es) Nuevas 5-fenoxialquil-tiazolidin-2,4-dionas, procedimientos para obtenerlas, nuevos compuestos intermedios de estos procedimientos ycomposiciones farmaceuticas que contienen las nuevas 5-fenoxialquil-tiazolidin- 2,4-dionas
MX9204138A (es) Compuestos ditiano, procedimiento para su obtencion y medicamentos que los contienen
DK0479546T3 (da) Piperazinderivater
IT1106280B (it) Procedimento per produrre poli-idrossicomposti di basso peso molecolare
FR2386592A1 (fr) Dispersion aqueuse et composition aqueuse de revetement a base d'urethane-diamine
IT1254931B (it) Stabilizzanti polisilossanici contenenti gruppi fenolici stericamente impediti e gruppi ossammidici.
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
FR2421900A1 (fr) Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
ID1040B (id) Senyawa-senyawa hidrazon yang secara farmasi efektif melawan tumor
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
BR0309988A (pt) Composto, composição farmacêutica, métodos para tratar ou melhorar doenças ou condições proliferativas e doenças inflamatórias, e, uso de um composto
FR2401907A1 (fr) Derives de 2-hydroxy-benzamide et leur application comme fongicides
ES2082894T3 (es) Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel.
CO5080802A1 (es) Nuevos compuestos heterociclicos inhibidores de la fosfodiesteresa iv y su formulacion y uso como productos farmaceuticos
ES2036238T3 (es) Derivados de hidroxietil-azolilo.
ES2043515B1 (es) Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina.
ES378824A1 (es) Procedimiento para la preparacion de lactonas de acido hi- droxicrotonico.
UY26498A1 (es) Pirroles sustituidos
FR2381755A1 (fr) Sels metalliques d'acides hydroxy-benzoiques utilisables comme stabilisants de polymeres